WASATCH ADVISORS INC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-10 5:58 pm Purchase |
2022-02-11 | 13G | ARS Pharmaceuticals, Inc. SPRY |
WASATCH ADVISORS INC | 1,775,690 5.100% |
1,775,690![]() (New Position) |
Filing |